Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.
2.

Direct oral anticoagulant (DOAC)-mediated vasodilation: Role of nitric oxide.

Mabley J, Patel JP, Sayed A, Arya R, Scutt G.

Thromb Res. 2019 Apr;176:36-38. doi: 10.1016/j.thromres.2019.02.014. Epub 2019 Feb 12. No abstract available.

PMID:
30772641
3.

Progress in the monitoring of direct oral anticoagulant therapy.

Patel JP, Byrne RA, Patel RK, Arya R.

Br J Haematol. 2019 Mar;184(6):912-924. doi: 10.1111/bjh.15756. Epub 2019 Jan 29. Review.

PMID:
30697708
4.

Women's views, adherence and experience with postnatal thromboprophylaxis.

Guimicheva B, Patel JP, Roberts LN, Subramanian D, Arya R.

Thromb Res. 2019 Jan;173:85-90. doi: 10.1016/j.thromres.2018.11.020. Epub 2018 Nov 22.

PMID:
30500674
5.

Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900.

Fernandez HF, Sun Z, Litzow MR, Luger SM, Paietta E, Racevskis J, Levine RL, Patel JP, Abdel-Wahab O, Ketterling RP, Dewald GW, Bennett JM, Rowe JM, Lazarus HM, Tallman MS.

Haematologica. 2019 Apr;104(4):e147-e150. doi: 10.3324/haematol.2018.197277. Epub 2018 Nov 22. No abstract available.

6.

Venous thromboembolism and women's health.

Speed V, Roberts LN, Patel JP, Arya R.

Br J Haematol. 2018 Nov;183(3):346-363. doi: 10.1111/bjh.15608. Epub 2018 Oct 18. Review.

PMID:
30334572
7.

Factors influencing the recruitment of lactating women in a clinical trial involving direct oral anticoagulants: a qualitative study.

Zhao Y, Ding A, Arya R, Patel JP.

Int J Clin Pharm. 2018 Dec;40(6):1511-1518. doi: 10.1007/s11096-018-0734-5. Epub 2018 Oct 10.

8.

History of eczema is associated with more severe hospital course in children hospitalized for asthma.

Liu M, Patel JP, Huang E, Ong PY.

Ann Allergy Asthma Immunol. 2018 Dec;121(6):735-736. doi: 10.1016/j.anai.2018.08.017. Epub 2018 Aug 27. No abstract available.

PMID:
30165107
9.

Associations between illness beliefs, medication beliefs, anticoagulation-related quality of life, and INR control: Insights from the Switching Study.

Bartoli-Abdou JK, Patel JP, Xie R, Dzahini O, Vadher B, Brown A, Roberts LN, Patel RK, Arya R, Auyeung V.

Res Pract Thromb Haemost. 2018 Jun 7;2(3):497-507. doi: 10.1002/rth2.12116. eCollection 2018 Jul.

10.

The impact of body weight on rivaroxaban pharmacokinetics.

Barsam SJ, Patel JP, Roberts LN, Kavarthapu V, Patel RK, Green B, Arya R.

Res Pract Thromb Haemost. 2017 Oct 9;1(2):180-187. doi: 10.1002/rth2.12039. eCollection 2017 Oct.

11.

Sub therapeutic rivaroxaban plasma concentrations following administration via Percutaneous Endoscopic Gastrostomy (PEG) feeding tubes - A note of caution.

Byrne R, Brown A, Patel JP, Czuprynska J, Roberts LN, Patel RK, Arya R.

Thromb Res. 2018 Aug;168:102-103. doi: 10.1016/j.thromres.2018.06.016. Epub 2018 Jun 19. No abstract available.

PMID:
29957474
12.

The perils of inhibiting deficient factors.

Sayar Z, Speed V, Patel JP, Patel RK, Arya R.

J Thromb Haemost. 2018 Jun 8. doi: 10.1111/jth.14195. [Epub ahead of print]

PMID:
29883037
13.

Synthesis and characterization of epoxy resin of 9,9'-bis-(3,5-dibromo-4-hydroxyphenyl) anthrone-10 and its jute composite.

Thanki JD, Patel JP, Parsania PH.

Des Monomers Polym. 2018 Jan 30;21(1):9-17. doi: 10.1080/15685551.2017.1421008. eCollection 2018.

14.

Prothrombin times in the presence of edoxaban - in-vivo experience from King's College hospital.

Patel JP, Chitongo PB, Dighe P, Roberts LN, Vadher B, Patel RK, Arya R.

Br J Haematol. 2019 Feb;184(3):455-456. doi: 10.1111/bjh.15101. Epub 2018 Jan 7. No abstract available.

PMID:
29315483
15.

Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study.

Bartoli-Abdou JK, Patel JP, Crawshaw J, Vadher B, Brown A, Roberts LN, Patel RK, Arya R, Auyeung V.

Thromb Res. 2018 Feb;162:62-68. doi: 10.1016/j.thromres.2017.12.021. Epub 2018 Jan 2.

16.
17.

Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient.

Patel JP, Lee EH, Mena-Hurtado CI, Walker CN.

Curr Cardiol Rep. 2017 Aug 24;19(9):89. doi: 10.1007/s11886-017-0889-z. Review.

PMID:
28836189
18.

Effects of metformin on endothelial health and erectile dysfunction.

Patel JP, Lee EH, Mena CI, Walker CN.

Transl Androl Urol. 2017 Jun;6(3):556-565. doi: 10.21037/tau.2017.03.52. Review.

19.

Current challenges and future prospects in oral anticoagulant therapy.

Czuprynska J, Patel JP, Arya R.

Br J Haematol. 2017 Sep;178(6):838-851. doi: 10.1111/bjh.14714. Epub 2017 Jun 2. Review.

PMID:
28573648
21.

Patient-centric medical notes: Identifying areas for improvement in the age of open medical records.

Lee EH, Patel JP, Fortin AH 6th.

Patient Educ Couns. 2017 Aug;100(8):1608-1611. doi: 10.1016/j.pec.2017.02.018. Epub 2017 Feb 22.

PMID:
28242141
22.

Managing direct oral anticoagulants in patients undergoing dentoalveolar surgery.

Patel JP, Woolcombe SA, Patel RK, Obisesan O, Roberts LN, Bryant C, Arya R.

Br Dent J. 2017 Feb 24;222(4):245-249. doi: 10.1038/sj.bdj.2017.165.

PMID:
28232717
23.

A statistical method to calculate blood contamination in the measurement of salivary hormones in healthy women.

Behr GA, Patel JP, Coote M, Moreira JCF, Gelain DP, Steiner M, Frey BN.

Clin Biochem. 2017 May;50(7-8):436-439. doi: 10.1016/j.clinbiochem.2016.12.005. Epub 2016 Dec 16.

PMID:
27989492
24.
25.
26.

Clinical Experience of Prescribing Dabigatran Etexilate With Dronedarone: The Role of Therapeutic Drug Monitoring.

Lock J, Patel RK, Brookes C, Patel JP.

Ther Drug Monit. 2016 Dec;38(6):813-814. No abstract available.

PMID:
27479092
27.

Adherence to long-term anticoagulation treatment, what is known and what the future might hold.

Abdou JK, Auyeung V, Patel JP, Arya R.

Br J Haematol. 2016 Jul;174(1):30-42. doi: 10.1111/bjh.14134. Epub 2016 May 12. Review.

PMID:
27173746
28.

Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups.

Luskin MR, Lee JW, Fernandez HF, Abdel-Wahab O, Bennett JM, Ketterling RP, Lazarus HM, Levine RL, Litzow MR, Paietta EM, Patel JP, Racevskis J, Rowe JM, Tallman MS, Sun Z, Luger SM.

Blood. 2016 Mar 24;127(12):1551-8. doi: 10.1182/blood-2015-07-657403. Epub 2016 Jan 11.

29.

Measurement of Postreplicative DNA Metabolism and Damage in the Rodent Brain.

Patel JP, Sowers ML, Herring JL, Theruvathu JA, Emmett MR, Hawkins BE, Zhang K, DeWitt DS, Prough DS, Sowers LC.

Chem Res Toxicol. 2015 Dec 21;28(12):2352-63. doi: 10.1021/acs.chemrestox.5b00359. Epub 2015 Nov 24.

PMID:
26447562
30.

Pressure-Flow Experimental Performance of New Intravascular Blood Pump Designs for Fontan Patients.

Chopski SG, Fox CS, Riddle ML, McKenna KL, Patel JP, Rozolis JT, Throckmorton AL.

Artif Organs. 2016 Mar;40(3):233-42. doi: 10.1111/aor.12549. Epub 2015 Sep 2.

PMID:
26333131
31.

Heavy menstrual bleeding on rivaroxaban.

Ferreira M, Barsam S, Patel JP, Czuprynska J, Roberts LN, Patel RK, Arya R.

Br J Haematol. 2016 Apr;173(2):314-5. doi: 10.1111/bjh.13583. Epub 2015 Jul 27. No abstract available.

PMID:
26212626
32.

Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?

Patel JP, Frey BN.

Neural Plast. 2015;2015:708306. doi: 10.1155/2015/708306. Epub 2015 May 13. Review.

33.

Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis.

Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M.

Circulation. 2015 Jul 21;132(3):194-204. doi: 10.1161/CIRCULATIONAHA.114.013267. Epub 2015 May 20. Review.

34.

New oral anticoagulants: dosing and monitoring.

Patel JP, Couchman L, Chitongo PB, Flanagan RJ, Arya R.

BMJ. 2015 May 19;350:h2655. doi: 10.1136/bmj.h2655. No abstract available.

PMID:
25991429
35.

Nijmegen breakage syndrome detected by newborn screening for T cell receptor excision circles (TRECs).

Patel JP, Puck JM, Srinivasan R, Brown C, Sunderam U, Kundu K, Brenner SE, Gatti RA, Church JA.

J Clin Immunol. 2015 Feb;35(2):227-33. doi: 10.1007/s10875-015-0136-6. Epub 2015 Feb 13.

36.

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.

Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM.

Clin Toxicol (Phila). 2015 Mar;53(3):156-63. doi: 10.3109/15563650.2015.1004580. Epub 2015 Feb 8.

PMID:
25661675
37.

Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.

Chen L, Chen W, Mysliwski M, Serio J, Ropa J, Abulwerdi FA, Chan RJ, Patel JP, Tallman MS, Paietta E, Melnick A, Levine RL, Abdel-Wahab O, Nikolovska-Coleska Z, Muntean AG.

Leukemia. 2015 Jun;29(6):1290-300. doi: 10.1038/leu.2015.18. Epub 2015 Feb 4.

38.

Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperium.

Patel JP, Patel RK, Roberts LN, Marsh MS, Green B, Davies JG, Arya R.

BMC Pregnancy Childbirth. 2014 Nov 19;14:384. doi: 10.1186/s12884-014-0384-0.

39.

Normal prothrombin times in the presence of therapeutic levels of apixaban--in-vivo experience from King's College Hospital.

Patel JP, Chitongo PB, Czuprynska J, Roberts LN, Patel RK, Arya R.

Br J Haematol. 2015 Apr;169(1):152-3. doi: 10.1111/bjh.13187. Epub 2014 Oct 14. No abstract available.

PMID:
25312941
40.

Impact of gold mining associated with mercury contamination in soil, biota sediments and tailings in Kenya.

Odumo BO, Carbonell G, Angeyo HK, Patel JP, Torrijos M, Rodríguez Martín JA.

Environ Sci Pollut Res Int. 2014 Nov;21(21):12426-35. doi: 10.1007/s11356-014-3190-3. Epub 2014 Jun 19.

PMID:
24943890
41.

Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.

Rampal R, Al-Shahrour F, Abdel-Wahab O, Patel JP, Brunel JP, Mermel CH, Bass AJ, Pretz J, Ahn J, Hricik T, Kilpivaara O, Wadleigh M, Busque L, Gilliland DG, Golub TR, Ebert BL, Levine RL.

Blood. 2014 May 29;123(22):e123-33. doi: 10.1182/blood-2014-02-554634. Epub 2014 Apr 16.

42.

Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry.

Gous T, Couchman L, Patel JP, Paradzai C, Arya R, Flanagan RJ.

Ther Drug Monit. 2014 Oct;36(5):597-605. doi: 10.1097/FTD.0000000000000059.

PMID:
24695356
43.

The current status of bridging anticoagulation.

Patel JP, Arya R.

Br J Haematol. 2014 Mar;164(5):619-29. doi: 10.1111/bjh.12644. Epub 2013 Nov 13. Review.

PMID:
24224681
44.

Population pharmacokinetics of enoxaparin during the antenatal period.

Patel JP, Green B, Patel RK, Marsh MS, Davies JG, Arya R.

Circulation. 2013 Sep 24;128(13):1462-9. doi: 10.1161/CIRCULATIONAHA.113.003198. Epub 2013 Aug 12.

PMID:
23940396
45.

Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies.

Oyer JA, Huang X, Zheng Y, Shim J, Ezponda T, Carpenter Z, Allegretta M, Okot-Kotber CI, Patel JP, Melnick A, Levine RL, Ferrando A, Mackerell AD Jr, Kelleher NL, Licht JD, Popovic R.

Leukemia. 2014 Jan;28(1):198-201. doi: 10.1038/leu.2013.204. Epub 2013 Jul 4. No abstract available.

46.

More on normal prothrombin times in the presence of therapeutic levels of rivaroxaban--early experience from King's College Hospital.

Patel JP, Roberts LN, Chitongo PB, Patel RK, Arya R.

Br J Haematol. 2013 Sep;162(5):717-8. doi: 10.1111/bjh.12423. Epub 2013 Jun 15. No abstract available.

PMID:
23772869
47.

Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia.

DiNardo CD, Propert KJ, Loren AW, Paietta E, Sun Z, Levine RL, Straley KS, Yen K, Patel JP, Agresta S, Abdel-Wahab O, Perl AE, Litzow MR, Rowe JM, Lazarus HM, Fernandez HF, Margolis DJ, Tallman MS, Luger SM, Carroll M.

Blood. 2013 Jun 13;121(24):4917-24. doi: 10.1182/blood-2013-03-493197. Epub 2013 May 2.

48.

Estimation of annual effective dose and radiation hazards due to natural radionuclides in Mount Homa, southwestern Kenya.

Otwoma D, Patel JP, Bartilol S, Mustapha AO.

Radiat Prot Dosimetry. 2013 Aug;155(4):497-504. doi: 10.1093/rpd/nct031. Epub 2013 Mar 13.

PMID:
23486485
49.

Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.

Meyer JA, Wang J, Hogan LE, Yang JJ, Dandekar S, Patel JP, Tang Z, Zumbo P, Li S, Zavadil J, Levine RL, Cardozo T, Hunger SP, Raetz EA, Evans WE, Morrison DJ, Mason CE, Carroll WL.

Nat Genet. 2013 Mar;45(3):290-4. doi: 10.1038/ng.2558. Epub 2013 Feb 3.

50.

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?

Patel JP, Levine RL.

Hematology Am Soc Hematol Educ Program. 2012;2012:28-34. doi: 10.1182/asheducation-2012.1.28. Review.

PMID:
23233557

Supplemental Content

Loading ...
Support Center